新吡咯並 [3，2-D] 嘧啶-4-酮衍生物以及它們的治療用途

• 收藏
• 分享

专利权人:

ASTRAZENECA AB

发明人:

BOEGEVIG, ANDERS,LO-ALFREDSSON, YVONNE,PIVONKA, DONALD,TIDEN, ANNA-KARIN

申请号：

HK08105257.9

公开号：

HK1110859B

申请日:

2008.05.13

申请国别(地区):

HK

年份:

2012

代理人:

摘要：

There are disclosed novel compounds of formula (I) wherein R1, R12, L, X and Y are as defined in the specification, and pharmaceutically acceptable salts thereof； together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of the enzyme MPO and are thereby particularly useful in the treatment or prophylaxis of neuroinflammatory disorders, cardiovascular disorders and respiratory disorders.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/